Schering-Plough Temodal Launch In EU Planned For First Quarter 1999
Executive Summary
Schering-Plough is preparing for the EU launch of its oncologic agent Temodal (temozolomide) early in 1999, following a unanimous recommendation for approval by the Committee for Proprietary Medicinal Products.